PATIENT INFORMATION LEAFLET
Rabeprazol TecniGen 20 mg gastro-resistant tablets EFG
Rabeprazol sodium
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
-Keep this leaflet, as you may need to read it again.
-If you have any questions, ask your doctor or pharmacist.
-This medicine has been prescribed for you only. Do not give it to others, even if they have the same symptoms as you, as it may harm them.
-If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet.
1.What Rabeprazol TecniGen is and what it is used for
2.What you need to know before you start taking Rabeprazol TecniGen
3.How to take Rabeprazol TecniGen
4.Possible side effects
5.Storage of Rabeprazol TecniGen
6.Contents of the pack and additional information
Rabeprazol TecniGen contains the active ingredient rabeprazol sodium. Rabeprazol belongs to a class of medications known as “Proton Pump Inhibitors” (PPIs), which act by reducing the amount of acid produced by the stomach.
Rabeprazol is used to treat:
• “Gastroesophageal reflux disease” (GERD), which may include the appearance of
acid reflux. The cause of GERDis the passage of acid and food from the stomach into the
esophagus.
• Stomach ulcers or ulcers in the upper part of the small intestine (duodenal ulcers). If these
ulcers are infected with a bacteria called “Helicobacter pylori” (H. pylori),
you will need to take antibiotics. Taking Rabeprazol TecniGen and the antibiotics
together will eliminate the infection and the ulcer will heal. It will also prevent the infection and the reoccurrence of the ulcer.
• Zollinger-Ellison syndrome, a disease characterized by the production of
very high amounts of acid in the stomach.
Do not take Rabeprazol TecniGen
•If you are allergic to rabeprazol sodium, or to any of the other components of Rabeprazol TecniGen (listed in section 6).
•If you are pregnant or think you may be pregnant.
•If you are breastfeeding.
Do not take Rabeprazol if you are in any of the above situations. If you are unsure, consult your doctor or pharmacist before taking Rabeprazol TecniGen.
See also the Pregnancy and breastfeeding section.
Children
It should not be administered to children.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Rabeprazol TecniGen:
Inform your doctor or pharmacist if you have experienced liver and blood problems in some patients but often improve when treatment with Rabeprazol TecniGen is interrupted.
If you experience a skin rash, especially in sun-exposed areas, consult your doctor as soon as possible, as it may be necessary to interrupt treatment with Omeprazol TecniGen. Remember to mention any other symptoms you may notice, such as joint pain.
If you are unsure whether the above affects you, consult your doctor or pharmacist before taking Rabeprazol.
If you experience severe diarrhea (watery or bloody) with symptoms such as fever, abdominal pain, or sensitivity, stop taking Rabeprazol TecniGen and see your doctor immediately.
During treatment with rabeprazol, inflammation in your kidneys may occur. Among the signs and symptoms are: decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. You must notify these signs to your doctor.
Use of Rabeprazol TecniGen with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, including herbal medicines.
Particularly, inform your doctor or pharmacist if you are taking any of the following medications:
If you are unsure whether the above affects you, consult your doctor or pharmacist before taking Rabeprazol.
Pregnancy, breastfeeding, and fertility
Consult your doctor or pharmacist before using any medication during pregnancy or breastfeeding.
Driving and operating machinery
You may feel drowsiness while taking Rabeprazol. If this occurs, do not drive or operate tools or machinery.
Warnings about excipients:
It may cause a mild laxative effect because it contains mannitol.
Follow exactly the administration instructions of Rabeprazol TecniGen indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Medication intake
Adults and elderly patients
Gastroesophageal reflux disease (GERD)
Symptomatic treatment of moderate to severe symptoms (GERD symptomatic)
Treatment of more severe symptoms (GERD erosive or ulcerative)
Maintenance treatment of symptoms (GERD maintenance)
For stomach ulcers (peptic ulcers)
For duodenal ulcers
For ulcers caused by H. Pylori infection and to prevent recurrences
For more information on other medications used to treat H. pylori, read the prospectus for each one.
Zollinger-Ellison syndrome, where excess acid is produced in the stomach
If you are on long-term treatment, you will need to see your doctor at regular intervals for dose review and symptom check.
Use in children.This medication should not be administered to children.
Patients with liver problems.Consult your doctor, who will have special care in the initiation and during treatment with Rabeprazol TecniGen.
If you take more Rabeprazol TecniGen than you should
If you take more Rabeprazol TecniGen than you should, talk to your doctor or go to the hospital immediately. Bring the medication with you.
In case of overdose or accidental ingestion, consult the Toxicological Information Service (Telephone: 91 5620420).
If you forget to take Rabeprazol TecniGen
If you interrupt treatment with Rabeprazol TecniGen
Relief of symptoms usually occurs before the ulcer is completely healed.
It is essential not to interrupt treatment until your doctor tells you to.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Rabeprazol TecniGen can cause side effects, although not everyone will experience them.
Side effects are usually mild and improve without you stopping treatment.
Stop taking Rabeprazol TecniGen and see your doctor immediately if you notice any of the following side effects - you may need urgent medical treatment:
These side effects are rare (affect less than 1 in 1,000 people).
These side effects are very rare (affect less than 1 in 10,000 people).
Other possible side effects:
Frequent (affect less than 1 in 10 people)
Rarely (affect less than 1 in 100 people)
Rare (affect less than 1 in 1,000 people)
Other possible side effects (frequency unknown)
Do not worry about the list of side effects. You may not experience any of them.
If you experience side effects, consult your doctor or pharmacist, even if they are side effects that do not appear in this prospectus.
Keep out of the sight and reach of children.
Do not store at a temperature above 30 °C.
Do not refrigerate.
Do not use Rabeprazol TecniGen after the expiration date that appears on the packaging and on the blister after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point (or any other medication waste collection system) at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. In this way, you will help protect the environment.
Composition of Rabeprazol TecniGen
- The active ingredient is rabeprazol sodium. Each Rabeprazol TecniGen tablet contains 10 milligrams of rabeprazol sodium as the active ingredient
- The other components (excipients) are: Core: mannitol, trisodium phosphate, magnesium oxide, hydroxypropylmethylcellulose, low-substituted hydroxypropylcellulose, crospovidone, colloidal silicon dioxide, magnesium stearate. Coating: ethylcellulose, magnesium oxide, Eudragit L100 55, triethyl citrate, talc, titanium dioxide (E171), iron oxide red (E 172).
Appearance of the product and content of the packaging
Rabeprazol TecniGen 10 mg gastro-resistant tablets are presented as round, biconvex, pink tablets, without scoring in packs of 28 tablets.
Other presentations:
Rabeprazol TecniGen 20 mg gastro-resistant tablets : packs of 14 and 28 tablets.
Holder of the marketing authorization and Responsible for manufacturing:
Holder of the marketing authorization
Tecnimede España Industria Farmacéutica, S.A.
Avda. de Bruselas, nº 13. 3ºD
28108 - Alcobendas (Madrid)
Responsible for manufacturing:
Laboratorios Alter, S.A.
Mateo Inurria, 30
28036 Madrid
This prospectus was approved in September 2022.
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.